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ABSTRACT Food for human consumption is screened widely for the presence of
antibiotic-resistant bacteria to assess the potential for transfer of resistant bacteria to
the general population. Here, we describe an Enterobacter cloacae complex isolated
from imported seafood that encodes two carbapenemases on two distinct plasmids.
Both enzymes belong to Ambler class A -lactamases, the previously described IMI-2
and a novel family designated FLC-1. The hydrolytic activity of the novel enzyme
against aminopenicillins, cephalosporins, and carbapenems was determined.
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To combat antimicrobial resistance (AMR) effectively, it is important to monitorreservoirs that may be sources of transmission to humans. Relevant reservoirs are
those that may be attributed to the AMR genes found in the general population and
patients. Seafood has been implicated as a potential source of AMR genes entering
populations when several aquatic bacteria carrying carbapenemase genes were iden-
tified in seafood imported from Southeast Asia (1, 2). Often, these genes are chromo-
somally located in nonpathogenic aquatic bacterial species, limiting them as relevant
threats for the general population (3). However, more recent studies screening seafood
imported from Southeast Asia have found carbapenemases encoded in human patho-
gens or on conjugative plasmids (4–6). As such, seafood imported from countries with
high carbapenemase prevalence may need to be included in monitoring programs.
Proteins with carbapenemase activity fall into the three major Ambler classes A,
B, and D -lactamases (7). Genes of these classes have been described on mobile
genetic elements, such as plasmids and chromosomally integrated elements, which
adds to the concerns regarding these genes because they facilitate the spread of
these genes among both commensal and pathogenic bacteria (6, 8, 9). The family
of Enterobacteriaceae consists of many commensal, opportunistic, and infectious
species that can readily exchange genetic material. The organisms are collectively
referred to as carbapenemase-producing Enterobacteriaceae when they have ac-
quired and express one of these genes.
Recently, Enterobacter cloacae complex and Vibrio cholerae isolates have been
described with a distinctive phenotype of hydrolyzing penicillins, aztreonam, and
carbapenems but not extended-spectrum cephalosporins (10).
In March 2017, we isolated an E. cloacae complex isolate, designated 3442, on a
ChromID Carba plate (bioMérieux Benelux BV) from a sample of frozen vannamei white
shrimp (Litopenaeus vannamei) originating in India. Species identification was per-
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formed using matrix-assisted laser desorption ionization–time of flight mass spectrom-
etry (Bruker Microflex LT/SH, Bruker Daltonics, Billerica MA). Susceptibility testing was
performed with broth microdilution in the Sensititre panels EUVSEC and EUVSEC2
(Thermo Fisher, Waltham MA) and interpreted using epidemiological cutoff values for
cephalosporins and carbapenems as defined for Escherichia coli by EUCAST. The isolate
exhibited an unusual phenotype, i.e., non-wild type susceptible to carbapenems (mero-
penem, ertapenem, and imipenem) and susceptible to extended-spectrum cephalo-
sporins (cefotaxime, ceftazidime, and cefepime) (Table 1).
Complete genomic DNA was isolated using the Gentra Puregene kit (Qiagen), and
whole-genome sequencing was performed using Illumina MiSeq PE300 and ONT
MinIon sequencing. Hybrid assemblies were created using a SPAdes reconstructed
genome consisting of one chromosome and three plasmids. The chromosome data
were used to determine the MLST type as ST813, a sequence type first described last
year in companion animals in Japan (11).
Plasmid p3442-FLC-1 is 93 kb and carries a novel carbapenemase with close se-
quence similarity to blaFRI-1 (10). Plasmid p3442-IMI2 is 78 kb and carries the carbap-
enemase blaIMI-2. Both plasmids are closely related to the IncFII plasmids first described
in Yersinia spp. but have new FII-Y alleles (submitted to pubMLST and designated
FII-Y-9 and FII-Y-10) (12). The closest relative to both plasmids is pIMI-6, described in an
E. cloacae complex clinical isolate from Canada, which carries the carbapenemase
blaIMI-6 (8). The two IncFII-Y plasmids contain much overlap in their sequences, but both
plasmids appear to have lost significant amounts of genetic material, and we hypoth-
esize that these plasmids developed from a pair of complete IncFII-Y plasmids. Cur-
rently, the two plasmids together contain most of the functions of IncFII-Y plasmids, as
shown in Fig. S1 in the supplemental material in a BLAST ring image generator (13)
comparison with the E. cloacae complex plasmid pIMI-6 (8), although several regions
are absent in both plasmids.
To assess the mobility of these plasmids, transformation and conjugation experi-
ments were performed as previously described (14). Carbapenem-resistant transconju-
gants and transformants were tested for blaIMI and blaFRI. Out of 200 colonies, only
blaIMI-positive transconjugants and transformants were detected. Antibiograms of
transformants and transconjugants are included in Table 1. Whereas only p3442-IMI2
may be both transformed and conjugated into E. coli recipient cells, p3442-FLC-1 may
be transferred at lower frequencies, below the level of detection used in the current
experiments.
Although blaIMI-2 transformants and transconjugants were carbapenem resistant, we
hypothesized that the blaFRI-related gene may also have carbapenemase activity.
Because the plasmid carrying the gene could not be transformed or conjugated into E.
coli cells, the gene was cloned into an arabinose-inducible expression vector, pBAD-FLC
(Vectorbuilder), and expressed in E. coli LMG194 (pBAD TOP TA expression kit, Invitro-
gen, Saint-Aubin, France) (15). The MIC of E. coli LMG194 pBAD-FLC was determined by
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Ampicillin 64 64 4 64 4 64 4
Cefotaxime 0.25 0.25 0.25 0.25 0.25 2 0.25
Cefotaxime/clavulanic acid 0.25/4 0.06/4 0.06/4 0.12/4 0.12/4 0.12/4 0.06/4
Ceftazidime 0.5 0.5 0.5 0.5 0.5 1 0.5
Ceftazidime/clavulanic acid 0.12/4 0.25/4 0.25/4 0.25/4 0.25/4 0.25/4 0.25/4
Cefepime 0.12 0.25 0.06 0.25 0.12 0.5 0.12
Cefoxitin 64 16 8 8 16 8 8
Ertapenem 2 2 0.015 2 0.015 2 0.015
Imipenem 16 16 0.25 16 0.5 16 0.25
Meropenem 16 8 0.03 16 0.06 4 0.03
Temocillin 4 16 32 16 16 16 8
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FIG 1 Multiple sequence alignment of the amino acid sequences of class A carbapenemases. Residues that are
identical to the sequence of FLC-1 are shown as a period in the sequence; a dash indicates a gap that was inserted
during alignment. A colon underneath the sequence indicates a substitution of strong similar properties, and a dot
under the sequence indicates a substitution of a weak similar property. Numbering of the amino acids was done
according to the method described for class A -lactamases by Ambler et al. (24). Residues conserved among class
A -lactamases are shown in red, and residues conserved among class A carbapenemases are shaded in gray.
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broth microdilution after culture overnight in RPMI medium plus 0.2% glucose followed
by dilution in Mueller-Hinton broth containing 0.2% arabinose and incubation at 37°C
for 1 h to enable expression to start. Standard protocols were followed thereafter and
E. coli LMG194 and ATCC 25922 were used as negative controls. E. coli LMG194
pBAD-FLC showed resistance against carbapenems and extended-spectrum cephalo-
sporins (Table 1). The FRI variant was concluded to be a carbapenemase and is further
referred to as FRI-like carbapenemase-1 (blaFLC-1).
Multiple sequence alignments were made comparing FLC-1 with several members
of plasmid-encoded Ambler class A carbapenemases (Fig. 1). All conserved residues
among class A -lactamases were present. The most related protein family was that of
the French imipenemase (FRI), with 82% identity to FRI-1 and 87% to FRI-5 (10, 16, 17)
(Fig. 2).
As previously described for other Ambler class A carbapenemases, blaFLC-1 is pre-
ceded by a lysR-type regulator, transcribed in the opposite direction, which is predicted
to regulate the expression of the protein (18). This region was flanked by the remnants
of two insertion elements, related to IS3 and ISEc25, which were likely responsible for
the integration of the region onto an ancestor of the plasmid, which is also common
for Ambler class A carbapenemases (8).
The soluble protein fractions of arabinose-induced E. coli LMG194 pBAD-FLC and E.
coli LMG194 were prepared as described in the supplemental material, and their
biochemical properties were evaluated. Analysis of the periplasmic protein fractions by
SDS-PAGE showed induction of a protein between 25 and 35 kDa as expected (FLC-
1 molecular weight, 33 kDa; see Fig. S2 in the supplemental material). Hydrolysis of
various -lactam antibiotics was monitored with a Spark microplate reader (Tecan) at
23°C using 96-well UV-Star microplates. Phosphate-buffered saline (0.01% Triton X-100,
pH 7.4) was used as the assay buffer. The extinction coefficients for the -lactam
antibiotics studied were Δ235  900 M1 cm1 for ampicillin, Δ297  10,940 M1
cm1 for meropenem, Δ295  11,500 M1 cm1 for imipenem, Δ300  6,920 M1
cm1 for ertapenem, and Δ264  7,250 M1 cm1 for cefotaxime. To calculate kinetic
parameters, including Km and Vmax, the measured initial velocities of the hydrolysis of
the substrates were fit into the Michaelis-Menten equation using GraphPad Prism 7
software (see Fig. S3 in the supplemental material for Michaelis-Menten curves).
Initially, cytoplasmic fractions of E. coli containing the plasmid showed hydrolysis of
nitrocefin, while cytoplasmic fractions of E. coli lacking the plasmid did not (see Fig. S4a
FIG 2 Phylogram of FLC-1 and 10 representative class A -lactamases. Amino acid sequences were
analyzed by Clustal Omega using the neighbor-joining method. Branch lengths are proportional to the
number of amino acid changes.
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in the supplemental material). Expanding these measurements to several -lactam
antibiotics over time allowed for the determination of kinetic parameters of the
protein-expressing cells (Table 2). The enzymatic activity of FLC-1 clearly showed
greater efficiency of the enzyme toward carbapenems than toward cephalosporins (as
evident by the relative kcat/Km values) (Table 2), with activity against ceftazidime and
cefepime below the threshold of detection. Using nitrocefin as the substrate, the
inhibition of FLC-1 enzymatic activity by clavulanic acid was tested, and the 50%
inhibitory concentration was calculated (1.974  0.090 M) (Fig. S4b).
Class A carbapenemases include members of GES, KPC, SME, and IMI/NMC-A en-
zymes plus SFC-1 and SHV-38 (19). With the exception of GES-1, most class A carbap-
enemases demonstrate higher carbapenemase activity of various degrees relative to
extended-spectrum -lactamases (19–22). FRI-1 is the closest member of the class A
carbapenemases relative to FLC-1 and was found to be at least 15 times more efficient
in degrading carbapenems than extended-spectrum cephalosporins (10). Here, we
report a similar substrate preference for the FLC-1 enzyme, which hydrolyzes imipenem,
ertapenem, and meropenem with greater efficiency than the cephalosporins tested
(Table 2).
To control AMR and retain effective use of antimicrobials in human and veterinary
medicine, a complete and correct overview of the impact that these human and animal
reservoirs have on each other is essential. blaFLC-1 was detected here in a sample of raw
shrimp from India, but members of the FRI family, to which FLC is most closely related,
and IMI, NMC-a, and SME have been described in a various global reservoirs (8, 10, 16,
17, 21, 23). Reliable databases of acquired resistance genes and point mutations leading
to resistance are essential to determine the gene responsible for a particular resistant
phenotype. The complete analysis presented here of the novel carbapenemase FLC-1
in its complete genetic carrier context will aid in the future for the recognition of its
gene, blaFLC-1, and related carbapenemases.
Accession numbers. The whole-genome sequence of isolate 3442 was submitted to
GenBank, and the chromosome and individual plasmids are available under accession
numbers CP033466 to CP033469. The protein sequence of blaFLC-1 was submitted to
GenBank under accession number ATX60370.1.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/AAC
.02338-18.
SUPPLEMENTAL FILE 1, PDF file, 0.5 MB.
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TABLE 2 Kinetic parameters determined for the cytoplasmic fraction of E. coli LMG-194 producing FLC-1
Antibiotic Protein concn (g · ml)a,b Km (M) Vmax/g proteinc Relative kcat/Km
Ampicillin 5.53 1,649  174.2 (1,490  70)  103 1.00
Meropenem 100 32.4  9.3 (2.05  0.14)  103 0.07
Imipenem 17.68 177.2  12.5 (48.61  1.40)  103 0.30
Ertapenem 44.21 29.6  11.7 (6.34  0.67)  103 0.24
Cefotaxime 106.1 377.1  110.6 (7.85  1.25)  103 0.02
Ceftazidime NDd 65  103e
Cefepime NDd 34  103e
aProtein concentration of the cytoplasmic fraction.
bThe E. coli strain producing FLC and the nontransformed strain were used to prepare cytoplasmic fractions. The highest tested concentration of both preparations
was 176.83 g/ml. None of the tested antibiotics were hydrolyzed by the nontransformed E. coli cytoplasmic fraction.
cExpressed as M/s/g of protein.
dNot determinable.
eBecause no substrate hydrolysis was detected, the Vmax data for ceftazidime and cefepime have been reported as less than the limit of detection/g protein.
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